BioXcel Therapeutics Rings the Closing Bell

About This Event

BioXcel Therapeutics (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Vimal Mehta, CEO, rings the Closing Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore